n
decemb
seri
unknown
origin
case
acut
respiratori
ill
occur
wuhan
hubei
provinc
china
highthroughput
sequenc
show
diseas
caus
name
sever
acut
respiratori
syndrom
coronaviru
februari
world
health
organ
offici
chang
name
diseas
caus
coronaviru
diseas
covid
diseas
rapidli
spread
wuhan
area
worldwid
februari
chines
health
author
announc
confirm
case
novel
coronaviru
infect
death
case
report
provinciallevel
region
note
wuhan
case
death
confirm
day
suggest
much
higher
proport
sever
case
mortal
rate
wuhan
provinc
china
howev
clinic
characterist
patient
suffer
case
defin
progress
identifi
elimin
factor
predict
neg
outcom
key
improv
surviv
although
diffus
alveolar
damag
acut
respiratori
failur
main
featur
involv
organ
need
explor
lung
infect
viru
may
enter
blood
accumul
kidney
caus
damag
resid
renal
cell
inde
rna
found
plasma
patient
realtim
polymeras
chain
reaction
note
report
show
patient
sar
develop
acut
kidney
injuri
aki
mortal
aki
thu
understand
kidney
affect
urgent
warrant
larg
prospect
cohort
studi
adult
patient
tertiari
teach
hospit
branch
bed
design
critic
case
local
govern
aim
determin
preval
aki
patient
defin
associ
marker
kidney
diseas
death
patient
infect
baselin
characterist
total
patient
includ
studi
tabl
show
clinic
featur
patient
median
age
year
patient
male
median
durat
ill
onset
admiss
day
total
patient
report
comorbid
report
respect
chronic
kidney
diseas
chronic
obstruct
pulmonari
diseas
hypertens
diabet
tumor
mean
lymphocyt
count
ae
l
lower
limit
normal
patient
elev
level
highsensit
creactiv
protein
erythrocyt
sediment
rate
elev
level
procalcitonin
rare
coagulopathi
common
patient
addit
mean
serum
lactos
dehydrogenas
ae
ul
increas
especi
high
baselin
serum
creatinin
level
tabl
kidney
abnorm
admiss
serum
creatinin
blood
urea
nitrogen
bun
elev
patient
respect
estim
glomerular
filtrat
rate
mlmin
per
report
patient
hospit
peak
serum
creatinin
ae
mmoll
patient
proteinuria
rel
fewer
patient
hematuria
tabl
admiss
urethr
catheter
done
patient
due
applic
invas
mechan
ventil
indic
impact
catheter
abnorm
urinari
analysi
admiss
small
compar
patient
normal
serum
creatinin
enter
hospit
elev
serum
creatinin
predominantli
male
older
sever
ill
tabl
moreov
patient
elev
baselin
serum
creatinin
demonstr
higher
leukocyt
count
lower
lymphocyt
platelet
count
coagul
pathway
abnorm
includ
prolong
activ
partial
thromboplastin
time
higher
ddimer
common
patient
elev
baselin
serum
creatinin
percentag
patient
increas
procalcitonin
level
aspart
aminotransferas
lactos
dehydrogenas
coronaviru
diseas
consid
pandem
world
health
organ
articl
publish
issu
kidney
intern
first
studi
report
associ
kidney
diseas
abnorm
kidney
function
mortal
hospit
patient
cohort
approxim
patient
underli
kidney
diseas
evid
abnorm
kidney
function
acut
kidney
injuri
aki
hospit
stay
dosedepend
relationship
aki
stage
death
excess
risk
mortal
least
time
among
stage
aki
kidney
diseas
major
complic
signific
risk
factor
death
howev
data
studi
origin
singl
center
therefor
generaliz
cohort
characterist
could
confirm
shortterm
catastroph
outcom
death
discuss
nonetheless
studi
find
suggest
earli
identif
risk
intervent
provid
appropri
support
avoid
nephrotoxin
may
help
improv
prognosi
patient
also
higher
patient
elev
baselin
serum
creatinin
note
gap
peak
baselin
serum
creatinin
also
much
greater
patient
elev
baselin
serum
creatinin
tabl
incid
aki
inhospit
death
hospit
aki
occur
patient
incid
aki
significantli
higher
patient
elev
baselin
serum
creatinin
patient
normal
baselin
valu
tabl
figur
inhospit
death
occur
patient
median
time
death
day
interquartil
rang
day
incid
inhospit
death
patient
elev
baselin
serum
creatinin
significantli
higher
normal
baselin
serum
creatinin
tabl
associ
kidney
diseas
indic
inhospit
death
kaplanmei
analysi
reveal
significantli
higher
inhospit
death
rate
patient
kidney
abnorm
includ
elev
baselin
serum
creatinin
elev
baselin
bun
proteinuria
hematuria
aki
p
figur
univari
cox
regress
analysi
show
age
year
male
sex
sever
diseas
associ
inhospit
death
addit
kidney
diseas
indic
mention
also
associ
inhospit
death
tabl
adjust
age
sex
diseas
sever
comorbid
lymphocyt
count
follow
associ
inhospit
death
proteinuria
degre
hematuria
degre
elev
baselin
bun
serum
creatinin
peak
serum
creatinin
mmoll
aki
stage
figur
medic
medic
hospit
avail
thu
summar
medic
hospit
tabl
first
day
admiss
antiviru
antibiot
glucocorticoid
common
medic
among
patient
percentag
treatment
antiviru
p
glucocorticoid
p
medic
signific
higher
patient
aki
howev
come
specif
antiviru
medic
includ
umifenovir
ganciclovir
interferon
lopinavir
ritonavir
oseltamivir
ribavirin
signific
differ
patient
aki
without
throughout
hospit
percentag
medic
increas
especi
antivir
diuret
glucocorticoid
addit
percentag
diuret
hospit
significantli
higher
patient
aki
without
vs
p
larg
prospect
cohort
studi
conduct
tertiari
teach
hospit
branch
wuhan
china
observ
high
preval
kidney
diseas
hospit
patient
evid
kidney
diseas
elev
serum
creatinin
bun
valu
strikingli
presenc
kidney
diseas
associ
greater
inhospit
mortal
multipl
organ
involv
includ
liver
gastrointestin
tract
kidney
report
cours
sar
recent
patient
one
possibl
explan
high
preval
kidney
involv
hospit
admiss
patient
past
histori
chronic
kidney
diseas
patient
proinflammatori
state
function
defect
innat
adapt
immun
cell
popul
known
higher
risk
upper
respiratori
tract
infect
pneumonia
note
median
time
period
first
symptom
sign
hospit
admiss
slightli
week
studi
altern
explan
mani
patient
could
admit
earli
stage
diseas
outbreak
acut
increas
larg
number
patient
limit
avail
hospit
bed
wuhan
earlier
admiss
hospit
might
help
prevent
diseas
spread
deterior
first
studi
show
associ
kidney
involv
poor
outcom
patient
found
patient
elev
baselin
serum
creatinin
like
admit
intens
care
unit
undergo
mechan
ventil
suggest
kidney
diseas
admiss
repres
higher
risk
deterior
report
previous
kidney
injuri
associ
increas
risk
death
patient
influenza
viru
subtyp
sar
studi
e
r
l
p
e
c
l
r
e
p
r
indic
kidney
involv
admiss
associ
higher
risk
inhospit
death
even
adjust
potenti
confound
observ
indic
poor
prognosi
regardless
initi
sever
gener
physic
condit
monitor
kidney
function
must
therefor
emphas
even
patient
mild
respiratori
symptom
alter
kidney
function
given
particular
attent
admiss
clinic
practic
earli
detect
treatment
renal
abnorm
includ
adequ
hemodynam
support
avoid
nephrotox
drug
may
help
improv
vital
prognosi
aki
result
abrupt
loss
kidney
function
strongli
associ
increas
mortal
morbid
found
patient
elev
serum
creatinin
like
develop
aki
hospit
consist
studi
sar
therefor
import
increas
awar
aki
enter
hospit
elev
serum
creatinin
cohort
detect
rate
aki
patient
keep
recent
report
small
sampl
size
much
higher
larg
observ
studi
may
explain
extrem
high
proport
sever
sick
patient
previou
case
seri
larg
observ
studi
cohort
studi
patient
sever
ill
may
explain
higher
detect
rate
aki
clinic
practic
wuhan
importantli
present
method
detect
aki
mainli
base
acut
chang
serum
creatinin
frequenc
serum
creatinin
test
substanti
impact
detect
rate
nationwid
crosssect
survey
hospit
adult
patient
china
detect
rate
aki
kidney
diseas
improv
global
outcom
kdigo
criteria
adjust
frequenc
serum
creatinin
determin
incid
aki
chines
hospit
adult
rose
thu
improv
earli
detect
kidney
injuri
frequent
serum
creatinin
measur
perform
patient
etiolog
kidney
diseas
involv
patient
like
multifactori
first
novel
coronaviru
may
exert
direct
cytopath
effect
kidney
tissu
support
detect
polymeras
chain
reaction
fragment
coronaviru
blood
urin
patient
sar
viru
recent
shown
novel
coronaviru
use
angiotensin
convert
enzym
cell
entri
receptor
ident
sarscov
report
recent
human
tissu
rnasequenc
data
demonstr
express
urinari
organ
kidney
nearli
higher
respiratori
organ
lung
therefor
kidney
diseas
may
caus
coronaviru
enter
kidney
cell
pathway
second
deposit
immun
complex
viral
antigen
virusinduc
specif
immunolog
effector
mechan
specif
tcell
lymphocyt
antibodi
may
damag
kidney
howev
kidney
microscopi
specimen
patient
sar
report
show
normal
glomerular
aspect
absenc
electrondens
deposit
support
activ
immunemedi
glomerulonephr
clearli
potenti
patholog
kidney
chang
patient
requir
studi
third
virusinduc
cytokin
mediat
might
exert
indirect
effect
renal
tissu
hypoxia
shock
rhabdomyolysi
fact
patient
viru
mild
moder
elev
serum
creatin
kinas
keep
observ
patient
admit
intens
care
unit
show
tendenc
toward
increas
creatin
kinas
level
patient
kidney
involv
studi
tend
increas
creatin
kinas
level
well
compar
medic
first
day
admiss
hospit
patient
aki
nonaki
found
patient
aki
like
higher
proport
glucocorticoid
lower
proport
antivir
drug
reninangiotensinaldosteron
system
inhibitor
treatment
admiss
differ
use
glucocorticoid
may
explain
condit
patient
aki
sever
thu
physician
tend
use
glucocorticoid
critic
ill
patient
even
controversi
use
glucocorticoid
patient
howev
oral
antivir
drug
includ
umifenovir
oseltamivir
lopinavir
ritonavir
prefer
moder
patient
admiss
given
function
receptor
safeti
potenti
effect
reninangiotensinaldosteron
system
inhibitor
patient
care
consid
potenti
harm
effect
may
account
low
proport
reninangiotensinaldosteron
system
inhibitor
use
physician
cohort
especi
patient
aki
higher
level
creatinin
admiss
due
small
number
patient
aki
bia
differ
therapi
patient
causal
relationship
drug
aki
patient
remain
undetermin
even
though
studi
includ
larg
number
patient
tertiari
teach
hospit
wuhan
sever
limit
first
accur
baselin
serum
creatinin
avail
may
led
underestim
aki
erron
associ
second
although
attempt
adjust
mani
confound
unmeasur
unknown
confound
might
play
role
third
clinic
data
patient
discharg
lack
could
assess
effect
longterm
outcom
precis
impact
kidney
structur
function
incid
chronic
kidney
diseas
patient
requir
investig
conclus
preval
kidney
diseas
patient
hospit
wuhan
china
high
adjust
confound
kidney
diseas
admiss
aki
hospit
associ
increas
risk
inhospit
death
clinician
increas
awar
kidney
diseas
hospit
patient
earli
detect
effect
intervent
kidney
involv
may
help
reduc
death
patient
particip
consecut
patient
admit
tongji
hospit
tongji
medic
colleg
huazhong
univers
scienc
technolog
januari
februari
enrol
tongji
hospit
locat
wuhan
hubei
provinc
major
endem
area
one
main
tertiari
teach
hospit
tongji
hospit
assign
respons
treatment
patient
sever
wuhan
govern
januari
patient
enrol
studi
diagnos
accord
guidanc
provid
chines
nation
health
commiss
diagnosi
criteria
follow
clinic
diagnosi
criteria
fever
respiratori
symptom
ii
leukopenia
lymphopenia
iii
computer
tomographi
scan
show
radiograph
abnorm
lung
clinic
diagnosi
criteria
posit
result
highthroughput
sequenc
realtim
polymeras
chain
reaction
assay
diagnos
pediatr
patient
exclud
patient
histori
mainten
dialysi
renal
transplant
also
exclud
studi
clinic
outcom
monitor
februari
final
date
followup
data
sourc
demograph
characterist
clinic
symptom
laboratori
data
medic
extract
electron
medic
record
laboratori
data
consist
complet
blood
count
liver
renal
function
test
examin
hemostasi
paramet
measur
highsensit
creactiv
protein
procalcitonin
lactat
dehydrogenas
creatin
kinas
serum
level
erythrocyt
sediment
rate
threshold
measur
given
laboratori
upper
limit
normal
serum
creatinin
men
women
mmoll
mmoll
respect
upper
limit
normal
bun
men
age
year
mmoll
respect
upper
limit
normal
bun
women
age
year
mmoll
respect
data
review
train
team
physician
estim
glomerular
filtrat
rate
calcul
chronic
kidney
diseas
epidemiolog
collabor
ckdepi
equat
date
diseas
onset
defin
day
first
symptom
notic
endpoint
inhospit
death
definit
sever
diseas
stage
accord
guidelin
diagnosi
treatment
trial
fifth
edit
publish
chines
nation
health
commiss
februari
sever
case
defin
respiratori
rate
breathsmin
ii
oxygen
satur
iii
pao
fio
ratio
mm
hg
critic
sever
case
defin
includ
follow
criteria
shock
respiratori
failur
requir
mechan
ventil
combin
organ
failur
admiss
intens
care
unit
aki
defin
increas
serum
creatinin
mgdl
within
hour
increas
serum
creatinin
baselin
within
day
accord
kdigo
hazard
ratio
hr
variabl
obtain
use
separ
proport
hazard
cox
model
adjust
age
sex
diseas
sever
comorbid
lymphocyt
count
sever
stage
base
guidelin
diagnosi
treatment
trial
fifth
edit
publish
chines
nation
health
commiss
februari
comorbid
includ
chronic
kidney
diseas
chronic
obstruct
pulmonari
diseas
hypertens
diabet
tumor
ci
confid
interv
e
r
l
p
e
c
l
r
e
p
r
criteria
baselin
serum
creatinin
defin
serum
creatinin
valu
admiss
date
aki
onset
defin
earliest
day
serum
creatinin
chang
meet
kdigo
criteria
stage
aki
determin
use
peak
serum
creatinin
level
aki
detect
increas
time
baselin
defin
aki
stage
respect
covari
base
review
literatur
sever
covari
select
analysi
potenti
confound
variabl
regress
analys
includ
age
sex
comorbid
diseas
sever
lymphocyt
count
statist
analysi
categor
variabl
summar
percentag
continu
variabl
express
mean
ae
sd
median
interquartil
rang
twosampl
test
wilcoxon
ranksum
test
use
continu
variabl
chisquar
test
fisher
exact
test
categor
variabl
appropri
cumul
rate
inhospit
death
determin
use
kaplanmei
method
associ
kidney
diseas
indic
inhospit
death
examin
use
cox
proport
hazard
regress
analysi
cox
proport
hazard
assumpt
test
schoenfeld
residu
violat
cox
proport
hazard
assumpt
detect
full
multivari
model
assess
interact
kidney
diseas
indic
age
sex
comorbid
diseas
sever
lymphocyt
count
cutoff
p
none
elig
retent
patient
miss
valu
proteinuria
hematuria
n
exclud
assess
associ
indic
inhospit
death
cox
proport
hazard
model
statist
analys
perform
use
r
softwar
version
r
foundat
vienna
austria
statist
signific
set
p
author
declar
compet
interest
